We are excited to announce that MedTech Innovator, the world’s largest accelerator of medical technology companies, has selected MicroGEM as one of 50 startups invited to participate in this year’s MedTech Accelerator Program. This marks another watershed moment for MicroGEM, underscoring promise of deploying molecular biology in the service of public health.
Every year, MedTech Innovator features the top 50 companies in the world in the MedTech industry. As a member of this tech cohort, MicroGEM will engage with a valuable network of business leaders, manufacturers, investors, and key industry stakeholders.
The MicroGEM team will participate in the MedTech Innovator Summit and Showcase at the WSGR Medical Device Conference San Francisco in June, where all 50 companies will have the opportunity to participate in an on-stage interactive program. In October, final awards totaling $500,000 and in-prizes will be given to the top innovators at the MedTech Innovator Showcase and Finals Competition at the MedTech Conference in Boston.
What does this mean for MicroGEM? More than 1,000 applicants from 49 countries and 43 states applied for this prestigious accelerator. This speaks volumes about not only the work we have been doing, but about our potential as a diagnostics innovator.
We are proud of the talented team that got us here and are eager to see where we go next as we continue to lean into our mission of democratizing molecular biology. Being selected for MedTech Innovator’s accelerator program will not only increase our visibility in the medical technology industry but will also spur innovation by enhancing our ability to collaborate with other industry leaders.
Read the full press release here.